Ausgabe 1/2003
Inhalt (12 Artikel)
Drugs to Promote Sinus Rhythm Reversion and Maintenance in Atrial Fibrillation—Why Amiodarone is Better
Stanley Nattel
Exercise Intolerance During Post-MI Heart Failure in Rats: Prevention with Supplemental Dietary Propionyl-L-Carnitine
Stanley G. Koh, Daniel A. Brenner, Donna H. Korzick, Marlena M. Tickerhoof, Carl S. Apstein, Kurt W. Saupe
Drugs Modifying Nitric Oxide Metabolism Affect Plasma Cholesterol Levels, Coagulation Parameters, Blood Pressure Values and the Appearance of Plasma Myocardial Necrosis Markers in Rabbits: Opposite Effects of L-NAME and Nitroglycerine
Arnaldo Pinelli, Silvio Trivulzio, Livio Tomasoni, Boris Bertolini, Sergio Brenna, Edgardo Bonacina, Roberto Accinni
Reduction of Infarct Size by Short-Term Pretreatment with Atorvastatin
Yochai Birnbaum, Taras Ashitkov, Barry F. Uretsky, Scott Ballinger, Massoud Motamedi
Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study
Emmanuel G. Manios, Hercules E. Mavrakis, Emmanuel M. Kanoupakis, Eleftherios M. Kallergis, Despina N. Dermitzaki, Despina C. Kambouraki, Panos E. Vardas
Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1
Bo Han, Yonathan Hasin
Genetic Polymorphisms in Emerging Cardiovascular Risk Factors and Response to Statin Therapy
Kimberly A. Dornbrook-Lavender, John A. Pieper
Effect of 17β-Estradiol on Soluble P-Selectin in Coronary Artery Bypass Grafting
Minxin Wei, Jari Laurikka, Pekka Kuukasjärvi, Erkki Pehkonen, Seppo Laine, Matti Tarkka
Low-Dose Flecainide Infusion Followed by Oral Pilsicainide is Highly Effective and Safe for Paroxysmal Atrial Fibrillation
Shunichi Nagai, Yasuchika Takeishi, Isao Kubota